AdminJul 22, 20203 minPipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing LossPIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with ...